PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies

Chen Liu; Teli Liu; Zhongyi Zhang; Ning Zhang; Peng Du; Yong Yang; Yiqiang Liu; Wei Yu; Nan Li; Michael A Gorin; Steven P. Rowe; Hua Zhu; Kun Yan; Zhi Yang

doi:10.2967/jnumed.119.235333

OtherClinical Investigations (Human)

PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies

Chen Liu, Teli Liu, Zhongyi Zhang, Ning Zhang, Peng Du, Yong Yang, Yiqiang Liu, Wei Yu, Nan Li, Michael A Gorin, Steven P. Rowe, Hua Zhu, Kun Yan and Zhi Yang

Journal of Nuclear Medicine February 2020, jnumed.119.235333; DOI: https://doi.org/10.2967/jnumed.119.235333

Chen Liu

1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Teli Liu

1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zhongyi Zhang

2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasonography, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ning Zhang

3 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peng Du

3 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yong Yang

3 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yiqiang Liu

4 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wei Yu

5 Department of Urology, Peking University First Hospital, Beijing, 100034, China, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nan Li

1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael A Gorin

6 The James Buchanan Brady Urological Institute and Department of Urology, and The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, US., United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Steven P. Rowe

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hua Zhu

1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kun Yan

2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasonography, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zhi Yang Professor

1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Article Figures & Data

Additional Files

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 64, Issue 2

February 1, 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies

Chen Liu, Teli Liu, Zhongyi Zhang, Ning Zhang, Peng Du, Yong Yang, Yiqiang Liu, Wei Yu, Nan Li, Michael A Gorin, Steven P. Rowe, Hua Zhu, Kun Yan, Zhi Yang

Journal of Nuclear Medicine Feb 2020, jnumed.119.235333; DOI: 10.2967/jnumed.119.235333

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies

Chen Liu, Teli Liu, Zhongyi Zhang, Ning Zhang, Peng Du, Yong Yang, Yiqiang Liu, Wei Yu, Nan Li, Michael A Gorin, Steven P. Rowe, Hua Zhu, Kun Yan, Zhi Yang

Journal of Nuclear Medicine Feb 2020, jnumed.119.235333; DOI: 10.2967/jnumed.119.235333

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network

Google Scholar

Clinical Investigations (Human)

Consecutive PSMA and AR PET imaging shows positive correlation to AR and PSMA protein expression in primary hormone naïve prostate cancer.
An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients
Towards Single Time Point Image-Based Dosimetry of ¹⁷⁷Lu-PSMA-617 Therapy

Show more Clinical Investigations (Human)

Clinical (Oncology: GU)

Consecutive PSMA and AR PET imaging shows positive correlation to AR and PSMA protein expression in primary hormone naïve prostate cancer.
An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients
Towards Single Time Point Image-Based Dosimetry of ¹⁷⁷Lu-PSMA-617 Therapy

Show more Clinical (Oncology: GU)

Keywords

Oncology: GU
PET
PET/CT
PSMA
biopsy
prostate cancer

Main menu

User menu

Search

PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies

Article Figures & Data

Additional Files

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Clinical Investigations (Human)

Clinical (Oncology: GU)

Similar Articles

Keywords